How and why did we decide to create a new method for diagnosing liver diseases?
In the modern world, liver diseases occupy one of the first places in prevalence among all human pathologies. Unfortunately, these ailments often do not manifest external symptoms, so in most cases they are detected only in an advanced stage, which increases the risk of death.
Routine methods - ultrasound or MRI - are effective in diagnosing liver tissue damage, but they do not allow timely detection of their initial forms of the disease. In this regard, modern approaches for identifying liver diseases at an early stage - radioisotope hepatography - are becoming increasingly relevant.
This innovative diagnostic method is based
Hepatography is a radiation diagnostic method that allows you to assess the condition of the liver and biliary tract. This method is based on the use of radioactive substances that are introduced into the patient's body.
Radioisotope research methods include the use of radioactive isotopes such as thallium-201, technetium-99m and others. These isotopes have a high ability to be absorbed in body tissues and emit gamma rays.
When performing radioisotope hepatography, the patient receives a dose of radioactive radiation. However, this test method is more sensitive and accurate than other diagnostic methods such as computed tomography or magnetic resonance imaging.